Skip to main content

Table 1 General profile of phenotypic drug susceptibility testing profile per year

From: Tuberculosis drug resistance in Bamako, Mali, from 2006 to 2014

Phenotypic drug susceptibility testing profile

2006

2007

2008

2009

2010

2011

2012

2013

2014

Total

Total number of isolates tested

18

53

33

15

10

29

53

87

39

337

Pan susceptible

18

37

22

2

1

16

34

63

17

210

S

0

1

3

0

0

0

2

8

2

16

I

0

0

1

1

0

2

4

2

2

12

R

0

1

0

0

0

0

0

0

1

2

E

0

0

0

0

0

0

1

0

0

1

S, I

0

1

2

2

0

0

1

5

5

16

S, I, E

0

1

0

0

0

0

1

1

0

3

S, R

0

0

0

0

0

0

0

0

1

1

S, R, E

0

0

0

0

0

0

0

0

1

1

S, I, R

0

2

0

0

2

0

0

0

1

5

I, R, E

0

2

1

1

0

1

0

0

0

5

I, R

0

1

1

0

0

3

1

0

4

10

S, I, R, E

0

7

3

9

7

7

9

8

5

55

Total # of MDR-TB per Year

0

12

5

10

9

11

10

8

10

75

% of MDR-TB per Year

0.00

22.6

15.2

66.7

90.0

37.9

18.9

9.2

25.6

22.3

  1. S streptomycin, I isoniazid, R rifampicin, E ethambutol, MDR-TB multidrug resistance (resistance to at least isoniazid and rifampicin)